The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of dissection is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that the procedure was to treat a moderately calcified, mildly tortuous distal left circumflex artery.The 2.5x23mm xience alpine stent delivery system was implanted; however, a distal edge dissection was noted.A 2.5x15mm xience alpine stent was used to treat the dissection.There was no adverse patient sequela and no clinically significant delay reported.No additional information was provided.
|